Silence Therapeutics (SLN) news
Recent news
Silence Therapeutics announces closing of upsized public offering and full exercise of underwriters’ option to purchase additional ADSs
AInvest Wire · Aug 14, 2026Silence Therapeutics prices upsized offering at $13.50 per ADS
Silence Therapeutics has priced its upsized public offering of 150 million American Depositary Shares (ADS) at $13.50 per ADS . The offering, which was increased from an initial proposal, reflects investor interest in the company’s pipeline and strategic direction. The ADSs are being offered under…
AInvest Wire · Aug 12, 2026Silence Therapeutics is said to plan pricing share Tuesday
Silence Therapeutics plc (NASDAQ: SLN) is reportedly planning to price its shares on Tuesday, according to recent market updates. The company, which operates in the biopharmaceutical sector, has drawn attention from investors and analysts as it moves forward with its capital-raising initiative.…
AInvest Wire · Aug 10, 2026Silence Therapeutics reports proposed offering of $150M of ADS
AInvest Wire · Aug 10, 2026Silence Therapeutics announces proposed public offering of $150 million of American depositary shares
AInvest Wire · Aug 10, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.